Femasys FEMY
NASDAQ FEMY
$2.96 +0.23 (+8.42%)
At close: Aug 21, 2026 · 4:00 PM EDT

Femasys (FEMY) Liabilities and Shareholders Equity (2020 - 2026)

Femasys' (FEMY) quarterly Liabilities and Shareholders Equity came in at $16.5 million in Q1 2026, up 24.23% YoY from $13.3 million in Q1 2025, and down 20.41% on a QoQ basis from $20.7 million in Q4 2025.

Femasys (FEMY) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

Femasys (FEMY) has 7 years of Liabilities and Shareholders Equity data on file, last reported at $16.5 million in Q1 2026.

  • Quarterly Liabilities and Shareholders Equity rose 24.23% year-over-year to $16.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $67.3 million (up 9.26% YoY) and the FY2025 annual result came in at $20.7 million, up 66.53% from the prior year.
  • Liabilities and Shareholders Equity fell to $16.5 million in Q1 2026, from $20.7 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $27.8 million in Q4 2023 to a low of $12.4 million in Q4 2024.
  • A 5-year average of $18.2 million and a median of $16.5 million in 2026 frame the typical range for Liabilities and Shareholders Equity.
  • The widest YoY moves for Liabilities and Shareholders Equity: up 75.74% in 2024, down 55.16% in 2024.
  • Tracing FEMY's Liabilities and Shareholders Equity over 5 years: stood at $16.9 million in 2022, then soared by 64.28% to $27.8 million in 2023, then sank by 55.16% to $12.4 million in 2024, then surged by 66.53% to $20.7 million in 2025, then dropped by 20.41% to $16.5 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $16.5 million (Q1 2026), $20.7 million (Q4 2025), and $16.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn 20.88 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn 50.73 Bn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn 31.10 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn 8.97 Bn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn 39.35 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn 4.08 Bn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn 14.24 Bn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn 12.48 Bn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn 19.79 Bn
10 Femasys 9.97 Mn 8.53 Mn 189,391.00 12.29 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 16.50 Mn
Dec 31, 2025 20.72 Mn
Sep 30, 2025 16.29 Mn
Jun 30, 2025 13.78 Mn
Mar 31, 2025 13.28 Mn
Dec 31, 2024 12.45 Mn
Sep 30, 2024 15.59 Mn
Jun 30, 2024 20.28 Mn
Mar 31, 2024 24.37 Mn
Dec 31, 2023 27.76 Mn
Sep 30, 2023 14.85 Mn
Jun 30, 2023 14.31 Mn
Mar 31, 2023 13.87 Mn
Dec 31, 2022 16.90 Mn
Sep 30, 2022 20.03 Mn
Jun 30, 2022 23.12 Mn
Mar 31, 2022 25.53 Mn
Dec 31, 2021 28.58 Mn
Sep 30, 2021 31.16 Mn
Jun 30, 2021 33.99 Mn